64 results
8-K
EX-10.1
OCUP
Ocuphire Pharma Inc
27 Nov 23
Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
8:45am
of this Section shall not apply with respect to the bona fide hiring and firing of the Company personnel to the extent such acts are part of Employee’s duties
424B5
OCUP
Ocuphire Pharma Inc
14 Aug 23
Prospectus supplement for primary offering
8:00am
research and development programs, vendor payables, hiring additional personnel, and capital expenditures.
We will not receive any proceeds from the sale … companies. These companies compete with Ocuphire in recruiting, hiring, and retaining qualified scientific and management personnel, engaging contract
8-K
EX-10.1
rtr0a
7 Nov 22
Ocuphire to Receive $35 Million Upfront, Nyxol Development Funding and Additional Potential Milestone Payments plus Tiered Double-Digit Royalties
4:16pm
8-K
EX-10.1
2482bgg13ci
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
424B5
56jfg n80x1
7 Jun 21
Prospectus supplement for primary offering
4:21pm
424B5
6bt5g4lv6dg
11 Mar 21
Prospectus supplement for primary offering
9:19am
424B4
8xivw
17 Feb 21
Prospectus supplement with pricing info
7:14am